However, these data question the role of CYP2E1 in oxidative damage-induced disease progression and suggest a possibility that other P450 enzymes such as CYP4A isozymes elevated in NAFLD and NASH may be involved in the progression of fatty liver diseases. The gene discussed is CYP2E1; the disease is metabolic dysfunction-associated steatohepatitis.